key: cord-0895082-hec6juqz
authors: Yang, Ruocong; Liu, Hao; Bai, Chen; Wang, Yingchao; Zhang, Xiaohui; Guo, Rui; Wu, Siying; Wang, Jianxun; Leung, Elaine; Chang, Hang; Li, Peng; Liu, Tiegang; Wang, Yi
title: Chemical composition and pharmacological mechanism of Qingfei Paidu Decoction and Ma Xing Shi Gan Decoction against Coronavirus Disease 2019 (COVID-19): in silico and experimental study
date: 2020-04-29
journal: Pharmacol Res
DOI: 10.1016/j.phrs.2020.104820
sha: 4a059265a05861f50954210df5d81f20b83ce1d7
doc_id: 895082
cord_uid: hec6juqz

Abstract The Coronavirus Disease 2019 (COVID-19) pandemic has become a huge threaten to global health, which raise urgent demand of developing efficient therapeutic strategy. The aim of the present study is to dissect the chemical composition and the pharmacological mechanism of Qingfei Paidu Decoction (QFPD), a clinically used Chinese medicine for treating COVID-19 patients in China. Through comprehensive analysis by liquid chromatography coupled with high resolution mass spectrometry (MS), a total of 129 compounds of QFPD were putatively identified. We also constructed molecular networking of mass spectrometry data to classify these compounds into 14 main clusters, in which exhibited specific patterns of flavonoids (45%), glycosides (15%), carboxylic acids (10%), and saponins (5%). The target network model of QFPD, established by predicting and collecting the targets of identified compounds, indicated a pivotal role of Ma Xing Shi Gan Decoction (MXSG) in the therapeutic efficacy of QFPD. Supportively, through transcriptomic analysis of gene expression after MXSG administration in rat model of LPS-induced pneumonia, the thrombin and Toll-like receptor (TLR) signaling pathway were suggested to be essential pathways for MXSG mediated anti-inflammatory effects. Besides, changes in content of major compounds in MXSG during decoction were found by the chemical analysis. We also validate that one major compound in MXSG, i.e. glycyrrhizic acid, inhibited TLR agonists induced IL-6 production in macrophage. In conclusion, the integration of in silico and experimental results indicated that the therapeutic effects of QFPD against COVID-19 may be attributed to the anti-inflammatory effects of MXSG, which supports the rationality of the compatibility of TCM.

Coronavirus Disease 2019 (COVID- 19) , which is caused by the novel coronavirus acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), has become a serious threaten for public health worldwide [1] . This novel coronavirus has relatively fast transmission speed, which make COVID-19 a highly contagious disease [2, 3] . As of March 26, 2020 , the epidemic has been sweeping through over 200 countries or regions, and the pandemic has spread to all continents except Antarctica [4] , and a total of 531,630 people worldwide were infected with the virus, of whom 24,065 died [5] .

Cytokine storm is considered to be one of the leading causes of the clinical deterioration of COVID-19. Through laboratory blood cell counts, lymphopenia was detected in 83.2% of the patients upon admission, the proportion of which was higher in those with severe illness than non-severe cases [6] . Meanwhile, 36.2% of patients had thrombocytopenia, and 33.7% of patients had leukopenia [6] . The reduction of white blood cells and platelets in the bloodstream may be a result of the overmobilization and aggregation of immune cells in the lesion area for inflammation control. The occurrence of immune cells detachment from blood vessels increases the J o u r n a l P r e -p r o o f risk of excessive immune response and directly leads to cytokine storms [7] . When a large number of immune cells are concentrated in the lesion area, a great amount of cytokines are secreted through positive feedback stimulation between each other.

Consequently, the immune cells will be activated excessively, which cause tissue damage in the lesion area, as well as severe immune overreaction in the body. This pathological process may directly leads to hypoxemia, shock, and multiple organs failure [8] . Therefore, reducing the excessive aggregation and response of immune cells is important for the prevention of cytokine storms and is beneficial for patient outcomes.

According to a World Health Organization (WHO) commentary, there are currently no effective drugs for the treatment of COVID-19 [9] , and the four most promising coronavirus treatments are still undergoing clinical trials [10] . Moreover, for controlling cytokine storms, only hormones and artificial liver blood purification systems are available at present [11] . However, the use of glucocorticoids cannot alleviate the progression of lung injury during COVID- 19 infection, yet the side effects of glucocorticoids may significantly reduce life quality of patients [12, 13] .

Meanwhile, the application of artificial liver blood purification systems also faces challenges as this technology has not been widely used in clinical. Therefore, the successful treatment of COVID-19 patients, especially those severe cases with severe cytokine storms, were impeded.

Since the outbreak of COVID-19, traditional Chinese medicine (TCM) has been used as first-line drugs to treat patients in China and has obtained positive curative effects. As of February 22, 2020, the rate of TCM treatment of COVID-19 in China was 87%, and the total effective rate of TCM treatment was 92%, of which only 5% of patients have worsened clinical manifestations [14] [15] [16] . Thus, the Chinese government decideded TCM as one of the recommended therapeutic options for the treatment of COVID-19 in the third version COVID-19 treatment guidelines, which was published on January 23, 2020 [17] . Besides, based on the theoretical system of J o u r n a l P r e -p r o o f TCM, physicians can combine and adjust prescriptions based on the symptoms of patients diagnosed. After nearly one month of clinical experimental observation, Qingfei Paidu Decoction, a formula consisting of 21 components including both herbs and mineral drugs, has been included in the 6 th edition of the guidelines as the primarily recommended formulae [18] . According to the 6 th and 7 th edition of COVID-19 treatment guidelines [19, 20] , Qingfei Paidu Decoction (QFPD) is effective for patients at all stages, and the total effective rate is 92.09% [21] . However, whether QFPD treat COVID-19 through regulating immune status and preventing cytokine storms has not been fully elucidated.

Here, we integrated multidisciplinary technologies to explore the pharmacological mechanism and to identify the major constituents of QFPD. The chemical constituents In summary, our study demonstrated Qingfei Paidu Decoction regulates the level of cytokine storms during the infection, which may be key mechanism underlying its therapeutic effects in COVID-19. These results may also guide future researches on TCM in infectious diseases and hyperimmune-related diseases.

The reference compounds wogonin, cryptochlorogenic acid, neochlorogenic acid, J o u r n a l P r e -p r o o f   chlorogenic acid, rosmarinic acid, mangiferin, irisflorentin, amygdalin, baicalin,   iristectorin, 3,4-dicaffeoylquinic acid, 3,5-dicaffeoylquinic acid, rutin, naringin fetal bovine serum, trypsin-EDTA and antibiotics (100 U/ml penicillin G and 100 g/mL streptomycin) were obtained from Gibico BRL (Grand Island, NY, USA).

Poly(I:C) and Pam3CSK4 were purchased from Invitrogen (CA, USA). IL-6 ELISA kit was obtained from Boshide Co., Ltd (Wuhan, China).

Qingfei Paidu Decoction was prepared from 21 herbs, Herba Ephedrae (Ma Briefly, Sheng Shi Gao was decocted firstly, and then all raw materials were codecocted in water twice (1 h for each time, the amount of the solvent was ten and eight times of the total weight of herbs, respectively). A total of approximate 1.78 L decoction were collected. The extracts were centrifuged at 10, 000 rpm for 20 min, and the supernatants were subject to LC-MS analysis. 

The MS/MS data files were converted from the .wiff (Waters) standard data format to .mzXML format using the MSConvert software, within the ProteoWizard package.

All .mzXML data were then processed using MZmine 2 v40.1. The mass detection was performed setting the noise level at 5.0 E4. The ADAP chromatogram builder was used with a set of a minimum group size of scans of 5, a group intensity threshold of 100 000, a minimum highest intensity of 50 000 and a m/z tolerance of 0.001 Da (or 10 ppm). The ADAP wavelets deconvolution algorithm was used using S/N threshold 

Corresponding molecular networking was created according to the online workflow at GNPS (http://gnps.ucsd.edu) with a parent mass tolerance of 0.02 Da and an MS/MS fragment ion tolerance of 0.02 Da, the minimum cluster size of 1, run MScluster and filter precursor window tools were turned off. The network created with cosine score above 0.7 and more than four matched peaks. The spectra in the network were then searched against GNPS spectral libraries with a cosine score above 0.7 and at least 4 matched peaks. The molecular networking data were visualized using Cytoscape (ver.3.7.2).

After the compound network was created, potential therapeutic targets network for Qingfei Paidu Decoction were further established as previous studies [22] [23] [24] [25] [26] . First, we query and standardize the identified compound information by the Pubchem database [27] . As a result, all compounds were listed with CAS number or PubChem ID, which are for subsequent query work. Next, we collected the target points of each compound in the list through the ETCM [28] and SymMap databases [29] . At the same time, we searched the SMILE structure corresponding to each compound J o u r n a l P r e -p r o o f through the Pubchem database, entered the structure into the SWISS Target Prediction database [30] to predict possible targets, and collected targets with scores above 0.75 in the results. Next, we used the DAVID database [31] to enrich the included target genes and visualized the enrichment results with Cytoscape (ver.3.7.2) and power bi (ver. 2.79.5773.0).

At present, there are limited diagnostic indicators for COVID-19, and the variability in the detection process of the existing indicators directly leads to significant false negatives in the test. In comparison, the diagnostic system established according to the diagnosis of TCM mostly avoid false-negative results. Therefore, we 

After getting the potential therapeutic targets of Qingfei Paidu Decoction and the target-genes of COVID-19, we further established the intervention network between Qingfei Paidu Decoction and COVID-19. In order to further focus the curative effect of Qingfei Paidu Decoction on the regulation of the immune system, especially in the J o u r n a l P r e -p r o o f regulation process of innate immunity, we mapped the drug-disease network of Qingfei Paidu Decoction and COVID-19 on the toll-like signaling pathway. Results were visualized with wikipathway plugin of Cytoscape software.

Male SD rats (110±10 g, 8-9 weeks) were purchased from SPF (Beijing) Biotechnology Company. During housing, the animals were kept in standard polypropylene cages, and the room temperature and the humidity were maintained at 12/12-hour light-dark cycle. Animals eat and drink freely.

After three days of adaptive breeding, the weight of all rats was measured. 50 SD rats were randomly divided into five groups, ten rats/group. The groups were named as normal group (Normal), model group (Model), Ma Xing Shi Gan Decoction (MXSG), antibiotic group (moxifloxacin), and hormone group (prednisone acetate).

Next, the Model, MGXG, Antibiotic, and Hormone were received given 0.5 mg/ml LPS nebulization intervention, 30min per day for three consecutive days. At the same time, on the day after the first atomization, the MGXG group, hormone group, and antibiotic group were given the oral treatment of Ma Xing Shi Gan Decoction, moxifloxacin, and prednisone acetate, which were administered orally once a day for three consecutive days. All doses were converted according to the equivalent dose of 0.018 for humans and rats with reference to clinical guidelines. After the last treatment, all the rats were on the condition of free drinking but without food for 12 hours, then anesthetized with 10% chloral hydrate and further sacrificed for liver, lung thymus, and kidney samples. The tissues were quickly collected, weighed, and the tissue/weight index was calculated and then placed in liquid nitrogen for quick freezing, and then placed in a -80 °C refrigerator for later tests.

The total RNA from each of the different specimens was isolated from the lungs of rats of three groups (normal group, model group, and MXSG group) simultaneously using the RNeasy Mini-Kit (QIAGEN, Valencia, CA), as per the manufacturer's instructions. After extracting total RNA from the sample and digesting the DNA with J o u r n a l P r e -p r o o f DNase, enrich it with magnetic beads with Oligo (dT); then add a disruption reagent to break the mRNA into short fragments, use the disrupted mRNA as a template, and randomly use six bases. The primers are used to synthesize one-strand cDNA, and then a two-stranded reaction system is prepared to synthesize the two-stranded cDNA, and the double-stranded cDNA is purified; the purified double-stranded cDNA is then subjected to end repair, added with A tail, and connected to a sequencing adapter, and finally, PCR amplification is performed. After the library was qualified with the Agilent 2100 Bioanalyzer, it was sequenced using the Illumina HiSeqTM 2 sequencer to generate 125bp or 150bp double-ended data. After passing the quality inspection, sequencing was performed using an Illumina sequencer, and bioinformatics analysis were performed based on the results. Gut microbiota of rats in different group were analyzed as previous study [32] . This study used a larger set of gut microbiota profiles that were generated alongside those described in a recent study by Goodrich et al. [33] , which reported a smaller sample as it considered only complete twin pairs. The processing of fecal samples has been described previously [34] . Briefly, samples were collected by the individual at home and either bought to a clinical visit or posted on ice to the clinical research department on ice where it was stored at −80 °C. Frozen samples were extracted to obtain DNA, the V4 region of the 16S rRNA genes amplified, and amplicons sequenced using a multiplexed approach on the Illumina MiSeq platform. Sample reads were demultiplexed and paired-ends merged using a 200nt minimum overlap.

De novo chimera removal was carried out on the 16S rRNA gene sequencing per sample using UCHIME [35] . Remaining reads were collapsed to de novo operational taxonomic units (OTUs) at 97% identity using SUMACLUST within QIIME version 1.9.0 [36, 37] . OTU taxonomy was assigned by aligning representative sequences to the Greengenes v13_8 database using UCLUST in QIIME. Analyses were adjusted for sequencing depth throughout by using sample read count as a covariate.

Taxonomic abundances were generated by collapsing OTU counts at appropriate J o u r n a l P r e -p r o o f levels, followed by conversion to log-transformed relative abundances. Three alpha diversity metrics, namely the Shannon index, phylogenetic diversity, and raw OTU counts, were calculated using QIIME. Beta diversity was calculated as both weighted and unweighted UniFrac metrics, and principal coordinate analysis of the beta distances was carried out using the vegan package.

For histological evaluation, the formaldehyde-fixed lower lobe of the left lung was embedded in paraffin wax, serially sectioned, and stained with hematoxylin and eosin.

Histologic changes, including alveolar wall edema, congestion, hemorrhage, and inflammatory cell infiltration, were evaluated under a light microscope to assess pulmonary inflammation according to the previous report [38] .

The RAW264.7 cell lines were cultured in high glucose DMEM with 10% FBS and antibiotics (100 units/mL penicillin and 100 μg/mL streptomycin). The cells were seeded in 12-well plates at a density of 100000 cells. After 1 day, the cells were coincubated with LPS (100 ng/mL) or Poly(I:C) (10 μg/mL) + Pam3CSK4 (100 ng/mL) and test drug for 24h. Dexamethasone acts as positive drug. After that, the cell culture medium was collected for IL-6 concentration measurement by enzyme-linked immunosorbent assay (ELISA) kit.

Representative chromatograms obtained by UPLC-Q-TOF/MS are shown in Figure   1 . After analyzing the raw data, 151 peaks were caught as individual compounds.

Among these, a total of 129 constituents were identified or tentatively characterized from QFPD based on literature and database matching. The compounds identified from QFPD were listed in Supplementary Table S1, including 58 Fig. S1 ). Among them, 29 compounds were unambiguously identified by comparisons with reference standards in terms of retention time and mass spectra ( Supplementary Fig. S2 ). The number of chemical constituents of each herb and representative constituents chosen from identified list of QFPD was shown in Figure 2 , which suggested that GC, CH, HQ are the main sources of identified compounds.

MS/MS data were used to construct molecular networking of QFPD according to the classification of compound structures and its similarity in MS 2 spectra. As shown in Figure 3 , the colors of the nodes in the molecular networking represent the sources herb of the compounds, which clearly indicated that MH, GC, CH, SG, ZX chiefly contributed to the chemical composition of QFPD. The sectorial area of color corresponding to the peak area of each compound. The size of nodes corresponds to the peak height of each compound in the whole decoction. Based on the networking, we labeled the represent compounds on the nodes, as shown in Figure 4 . Flavonoids aggregated to form the largest cluster, while glycosides and saponins also formed typical clusters.

The potential therapeutic target-network of Qingfei Paidu Decoction was presented in Figure 5 . We firstly predicted and collected the targets of compounds identified by LC-MS. Qualified target information was obtained for 40 flavonoids, 7 glycosides, 5 terpenes, 3 carboxylic acids, 3 cholestanes, 2 saponins, 1 xanthenes, 1 heterocyclic, 1 benzopyrans, 1 benzofurans and 1 alkaloidoids. The links among the herbs, compound categories, and compounds were shown in Figure 5A . Then, we counted the number of targets corresponding to each drug based on the compound information contained in the herbal medicine (Fig. 5B) . The results showed that MH, GC, CH, HQ, ZW were the herbs with the highest number of corresponding targets. After merging all the target information and removing the duplicate target content, we next performed GO and KEGG enrichment analysis on the target information ( Fig. 5C and 5D ). As a J o u r n a l P r e -p r o o f result, in the GO enrichment analysis, QFPD played an interventional role by interfering with cellular processes, metabolic processes. The interventional effect was mainly on organelles and membrane structures, and the main targeted molecules were involved in protein binding process and the function of catalysis. KEGG analysis suggested that the effect of QFPD was mainly to interfere with viral infection-related pathways and cancer-related pathways. All the herb-compound-target information is in Supplementary Material 2.

The construction of the COVID-19 symptom target network is based on TCM diagnostic system. According to the diagnostic criteria in the 7 th edition of COVID-19 treatment guidelines, TCM classified COVID-19 patients into four categories based on patients' pathological process, including mild, moderate, severe, and critical.

Among them, the mild type included the syndrome of cold fluid-retention suspend in lung and the syndrome of stagnant and jamming dampness-heat in the lung; the moderate type was divided into the syndrome of dampness toxin and depression of lung and the syndrome of accumulation of cold fluid in the lung; the severe type contained the syndrome of dirty-toxicity blocking lung and the syndrome of flaring heat in qifen (also known as defense qi, a term describes qi is "fierce , bold and uninhibited" and unable to contained by the vessels and therefore flowing out side them ) and yingfen (also known as construction qi, which refer to the qi that forms the blood and flows with it in the vessels, helping to nourish the entire body) [39] ; the critical type had only the syndrome of internal blockade and external collapse. We Table 1) .

We further analyzed these targets from COVID-19. The distribution of targets from different categories was shown in Figure 6A . The results suggested that at different pathological stages (both class of mild, moderate, severe, and critical, or their divided categories), the targets that change during the pathological process are different. We then deduplicated, merged the target genes of the same class, and exhibited the results in the form of Venn diagrams (Fig. 6B ). There are 233 targets in all four stages, and 376 targets appear in three stages, suggesting that in the pathological process of COVID-19, many biological processes may be shared (Supplementary Material 3) . At the same time, in the transition phase, that is, mild phase to moderate phase, moderate phase to severe phase, severe phase to critical phase, the number of common targets appeared is relatively large, 77 between the mild and the moderate, 124 between the moderate and the severe, and between 82 the severe and the critical. To further find the regular of these targets, we merged, with no repetition, all the targets and then enriched these genes by GO and pathway (using the Reactome database) method. As a result, we found that targets were enriched in the regulation of a variety of biological processes and participated in the immune response process; the corresponding molecular functions of these genes were the docking, catalysis and molecular activity regulation of proteins; meanwhile, the positions of these targets correspond to subcellular organelles and cell membrane (Fig. 6C) . This result was similar to the target network results of Qingfei Paidu Decoction, suggesting that Qingfei Paidu Decoction could be used as a promising formula to intervene in the pathological process of COVID-19. Moreover, we enriched the results of the biological process J o u r n a l P r e -p r o o f from GO and the results of pathways from Reactome database, and discover the immune regulation cells was the core physiological and pathological process of the pathological process of COVID-19 (Fig. 6D) , which indicated that controlling the level of the immune response during the disease process was one of the crucial intervention to treating COVID-19.

As the Toll-like signaling pathway was one of the most critical pathways in the immune response to viral infections, we further investigate the effect of Qingfei Paidu Decoction for COVID-19 based on this pathway. We combined the potential therapeutic network of QFPD and the target network of COVID-19， and merged the result with the genes of the Toll-like signaling pathway. As a result, we found that a total of 24 genes are promising target genes of QFPD for COVID-19 (Figure 7) . Among the genes interfered by QFPD, six genes are reported as disease-related genes; 3 genes are target genes related to drug therapy, 12 genes are both disease-related genes and target genes, and 3 genes are background genes. When dissecting the compound-target relationships in the context of Toll-like receptor pathway, it is interesting to find out MH and GC, which belongs to Ma Xing Shi Gan Decoction, chiefly regulated the similar targets of QFPD. Figure 8B) . Conversely, the dissolution of glycyrrhizic acid was reduced during the co-decoction period, as shown in Figure 8C , suggesting that the potential interaction between alkaloids (such as ephedrine) and glycyrrhizic acid may affects the chemical composition of Ma Xing Shi Gan Decoction.

We 2020, the number of deaths has been up to 24,065, which is about 3.4% of the total confirmed cases [40] . In this present study, we construct a TCM symptom-target disease network of COVID-19 based on the diagnostic system of TCM, which is in 7 th edition of COVID-19 treatment guidelines and has been used in the clinical treatment of COVID-19 in China. We found that in addition to the immune response and activation of multiple immune cells, the pathological processes of COVID-19 also involve in the coagulation system.

Using in silico approaches including network pharmacology and molecular networking of MS data, we elucidated the chemical composition and potential mechanism of QFPD against COVID-19. A total of 129 compounds were identified from QFPD, while the targets of these compounds in the context of COVID-19 disease network l were generated. As a result, we found that Toll-like signaling pathway plays important roles in pharmacological mechanism of QFPD for treating As one of the components of QFPD, Ma Xing Shi Gan Decoction has been vastly used in the treatment of multiple epidemics caused by viruses [42] [43] [44] . Previous studies showed that Ma Xing Shi Gan Decoction can alleviate viral infection by regulating the expression of multiple cytokines, activating multiple innate immunerelated cells, and preventing pathogens from entering targeted host cells [45] [46] [47] . In this present study, LC-MS results suggested that the compatibility of Ma Xing Shi Gan Decoction increase the dissolution of ephedrine while reducing the dissolution of glycyrrhizic acid. As one of the primary material foundations of Ma Xing Shi Gan Decoction, ephedrine has an anti-platelet aggregation effect [48] . Combined with the results of lung transcriptomics in this study, Ma Xing Shi Gan Decoction may enhance the effect of the whole prescription through intervention on the coagulation system.

Meanwhile, glycyrrhizic acid, an indispensable compound in the whole recipe of Ma Xing Shi Gan Decoction, is a compound with a glucocorticoid-like effect [49] .

Clinical data shown that glycyrrhizic acid has excellent anti-inflammatory, antioxidant and other suppressive immune response [50] . However, on the other hand, it may exerts side effects with potent cytotoxicity and bone damage characteristics [51] .

This suggests that the therapeutic window of glycyrrhizic acid may be narrow.

However, the co-decoction of Ma Xing Shi Gan Decoction lead to the controlled J o u r n a l P r e -p r o o f content of glycyrrhizic acid within a suitable dose range to exert anti-inflammatory effects without significant side effects. Due to limitation of time, whether glycyrrhizic acid and other major constituents of QFPD regulated other nodes and pathways in COVID-19 disease model are not fully investigated. Further research on the synergistic and additive effects of those compounds in QFPD will enhance our understanding on its pharmacological mechanism against COVID-19.

In this study, we illustrated the major chemical constituents as well as their potential targets of QFPD for treating COVID-19. By establishing a COVID-19 disease network and enriching the key nodes and pathways regulated by the active ingredients of QFPD, we found that Toll-like receptor signaling pathway play important role in pharmacological effects of QFPD. Interestingly, we found that Ma Xing Shi Gan Decoction, the core component of whole recipe may have a major contribution to the overall efficacy of QFPD. Further results of chemical analysis suggested that the contents of ephedrine and glycyrrhizic acid changed after decoction. Transcriptomic analysis of effects of Ma Xing Shi Gan Decoction in a rat model of pneumonia suggested that it regulated the coagulation system in the inflammatory state, which benefits QFPD to intervene the inflammatory storm caused by COVID-19. Our research provides an experimental and computational basis and research ideas for further discovery of TCM formula and botanical drug for the treatment of COVID-19.

The authors declare there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome. 

A novel coronavirus outbreak of global health concern

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia

Coronavirus COVID-19 Global Cases by Johns Hopkins CSSE. www.gisanddata.maps.arcgis.com

2019-20 coronavirus outbreak

Into the eye of the cytokine storm

Cytokine storm and sepsis disease pathogenesis

Off-label use of medicines for COVID-19

WHO launches global megatrial of the four most promising coronavirus treatments

Management of corona virus disease-19 (COVID-19): the Zhejiang experience

Glucocorticoids and Bone: Consequences of Endogenous and Exogenous Excess and Replacement Therapy

Long-term side glucocorticoids

Beijing: The total effective rate of traditional Chinese medicine treatment of new crown pneumonia is 92%

Established Xinguan Rehabilitation Clinic, TCM participated in the whole process of treatment

Traditional Chinese medicine for COVID-19 treatment

Notice on Printing and Distributing Pneumonia Diagnosis and Treatment Plan for New Coronavirus Infection (Trial Version)

Notice regarding the issuance of a new coronavirus pneumonia diagnosis and treatment plan

New Coronavirus Pneumonia Diagnosis and Treatment Program (Trial Version 7)

Clinical Observation of Qingfei Paidu Decoction in Treating COVID-19

Effects of Qijian mixture on type 2 diabetes assessed by metabonomics, gut microbiota and network pharmacology

Network pharmacology based investigation of the effects of herbal ingredients on the immune dysfunction in heart disease

Network topology and machine learning analyses reveal microstructural white matter changes underlying Chinese medicine Dengzhan Shengmai treatment on patients with vascular cognitive impairment

Network pharmacology based investigation into the effect and mechanism of Modified Sijunzi Decoction against the subtypes of chronic atrophic gastritis

Drug-symptom networking: Linking drug-likeness screening to drug discovery

PubChem 2019 update: improved access to chemical data

ETCM: an encyclopaedia of traditional Chinese medicine

SymMap: an integrative database of traditional Chinese medicine enhanced by symptom mapping

SwissTargetPrediction: a web server for target prediction of bioactive small molecules

Database for Annotation, Visualization, and Integrated Discovery

Gut microbiota associations with common diseases and prescription medications in a population-based cohort

Genetic Determinants of the Gut Microbiome in UK Twins

Human genetics shape the gut microbiome

UCHIME improves sensitivity and speed of chimera detection

QIIME allows analysis of high-throughput community sequencing data

A heritability-based comparison of methods used to cluster 16S rRNA gene sequences into operational taxonomic units

Dexmedetomidine-ketamine combination mitigates acute lung injury in haemorrhagic shock rats

Introduction to English Terminology of Chinese Medicine

COVID-19) Mortality Rate. www.worldometers.info

COVID-19: consider cytokine storm syndromes and immunosuppression

Implications of SARS TCM diagnosis and treatment in Beijing and Guangdong: 13 years of SARS

Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: a randomized trial

A Randomized Controlled Study of Maxing Shigan Decoction in the Treatment of Mild H1N1 Influenza

Ma Xing Shi Gan Decoction Attenuates PM2.5 Induced Lung Injury via Inhibiting HMGB1/TLR4/NFκB Signal Pathway in Rat

Mechanism by which ma-xing-shi-gan-tang inhibits the entry of influenza virus

The effects of Ma-Xing-Gan-Shi-Tang on respiratory resistance and airway leukocyte infiltration in asthmatic guinea pigs

Hemostatic effects of ephedrine

Glycyrrhizic acid and 18beta-glycyrrhetinic acid inhibit inflammation via PI3K/Akt/GSK3beta signaling and glucocorticoid receptor activation

Natural products in licorice for the therapy of liver diseases: Progress and future opportunities

Toxicological Effects of Glycyrrhiza glabra (Licorice): A Review